北京大学学报（医学版） ›› 2024, Vol. 56 ›› Issue (4): 562-564. doi: 10.19723/j.issn.1671-167X.2024.04.002
机器人手术时代的肾癌合并腔静脉瘤栓治疗策略
张树栋*(
),谢睿扬
- 北京大学第三医院泌尿外科，北京 100191
树栋 张*(),睿扬 谢
中图分类号:
- R737.1
| 1 |
Marshall FF , Dietrick DD , Baumgartner WA , et al. Surgical management of renal cell carcinoma with intracaval neoplastic extension above the hepatic veins[J]. J Urol, 1988, 139 (6): 1166- 1172.
doi: 10.1016/S0022-5347(17)42848-5 |
| 2 |
Reese AC , Whitson JM , Meng MV . Natural history of untreated renal cell carcinoma with venous tumor thrombus[J]. Urol Oncol, 2013, 31 (7): 1305- 1309.
doi: 10.1016/j.urolonc.2011.12.006 |
| 3 |
Tilki D , Nguyen HG , Dall-Era MA , et al. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus[J]. Eur Urol, 2014, 66 (3): 577- 583.
doi: 10.1016/j.eururo.2013.06.048 |
| 4 | 黄庆波, 彭程, 顾良友, 等. 肾肿瘤伴静脉瘤栓"301分级系统"及手术策略(附100例病例分析)[J]. 微创泌尿外科杂志, 2017, 6 (6): 328- 332. |
| 5 |
Aslam-Sohaib SA , Teh J , Nargund VH , et al. Assessment of tumor invasion of the vena caval wall in renal cell carcinoma cases by magnetic resonance imaging[J]. J Urol, 2002, 167 (3): 1271- 1275.
doi: 10.1016/S0022-5347(05)65280-9 |
| 6 | Zargar-Shoshtari K , Sharma P , Espiritu P , et al. Caval tumor thrombus volume influences outcomes in renal cell carcinoma with venous extension[J]. Urol Oncol, 2015, 33 (3): 112. |
| 7 | Tabbara MM, Gonzalez J, Ciancio G. Renal cell carcinoma with supradiaphragmatic tumor thrombus: Avoiding sternotomy and cardiopulmonary bypass[J]. Med Res Arch, 2022(2022-07-31)[20230-1-15]. https://pubmed.ncbi.nlm.nih.gov/36714035. |
| 8 |
Thiel DD , Lohse CM , Arnold ML , et al. Does left side renal cell carcinoma (RCC) with renal vein/vena cava thrombus predict worse prognosis than equivalent right side RCC tumor thrombus?[J]. Int Urol Nephrol, 2012, 44 (4): 1005- 1012.
doi: 10.1007/s11255-012-0168-2 |
| 9 |
Zhang Y , Bi H , Fu Y , et al. Cephalic inferior vena cava non-clamping technique versus standard procedure for robot-assisted laparoscopic level Ⅱ-Ⅲ thrombectomy: A prospective cohort study[J]. Int J Surg, 2023, 109 (6): 1594- 1602.
doi: 10.1097/JS9.0000000000000209 |
| 10 |
Cost NG , Delacroix SE , Jr. , Sleeper JP , et al. The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus[J]. Eur Urol, 2011, 59 (6): 912- 918.
doi: 10.1016/j.eururo.2011.02.032 |
| 11 |
Bigot P , Fardoun T , Bernhard JC , et al. Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: Is it useful?[J]. World J Urol, 2014, 32 (1): 109- 114.
doi: 10.1007/s00345-013-1088-1 |
| 12 |
Zhang Y , Li Y , Deng J , et al. Sorafenib neoadjuvant therapy in the treatment of high risk renal cell carcinoma[J]. PLoS One, 2015, 10 (2): e0115896.
doi: 10.1371/journal.pone.0115896 |
| 13 |
Field CA , Cotta BH , Jimenez J , et al. Neoadjuvant sunitinib decreases inferior vena caval thrombus size and is associated with improved oncologic outcomes: A multicenter comparative analysis[J]. Clin Genitourin Cancer, 2019, 17 (3): e505- e512.
doi: 10.1016/j.clgc.2019.01.013 |
| 14 |
Stewart GD , Welsh SJ , Ursprung S , et al. A Phase Ⅱ study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)[J]. Br J Cancer, 2022, 127 (6): 1051- 1060.
doi: 10.1038/s41416-022-01883-7 |
| 15 |
Zhang Z , Xiong L , Wu Z , et al. Neoadjuvant combination of pazopanib or axitinib and programmed cell death protein-1-activated dendritic cell-cytokine-induced killer cells immunotherapy may facilitate surgery in patients with renal cell carcinoma[J]. Transl Androl Urol, 2021, 10 (5): 2091- 2102.
doi: 10.21037/tau-21-406 |
| 16 |
Labbate C , Hatogai K , Werntz R , et al. Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy[J]. J Immunother Cancer, 2019, 7 (1): 66.
doi: 10.1186/s40425-019-0546-8 |
| 17 |
Hara T , Terakawa T , Hyodo T , et al. Pathological complete response of renal cell carcinoma with vena cava tumor thrombus to neoadjuvant TKI/IO combination therapy[J]. Urol Case Rep, 2021, 39, 101800.
doi: 10.1016/j.eucr.2021.101800 |
| 18 |
Powles T , Tomczak P , Park SH , et al. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial[J]. Lancet Oncol, 2022, 23 (9): 1133- 1144.
doi: 10.1016/S1470-2045(22)00487-9 |
| 19 |
Choueiri TK , Tomczak P , Park SH , et al. Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma[J]. N Engl J Med, 2021, 385 (8): 683- 694.
doi: 10.1056/NEJMoa2106391 |
| 20 |
Wu Z , Chen H , Chen Q , et al. Prognostic significance of grade discrepancy between primary tumor and venous thrombus in nonmetastatic clear-cell renal cell carcinoma: Analysis of the REMEMBER registry and implications for adjuvant therapy[J]. Eur Urol Oncol, 2024, 7 (1): 112- 121.
doi: 10.1016/j.euo.2023.06.006 |
| [1] | 舒帆,郝一昌,张展奕,邓绍晖,张洪宪,刘磊,王国良,田晓军,赵磊,马潞林,张树栋. 肾部分切除术治疗囊性肾癌的功能学和肿瘤学结果：单中心回顾性研究[J]. 北京大学学报（医学版）, 2024, 56(4): 667-672. |
| [2] | 应沂岑,杜毅聪,李志华,张一鸣,李新飞,王冰,张鹏,朱宏建,周利群,杨昆霖,李学松. 机器人辅助腹腔镜下颊黏膜补片输尿管成形术治疗复杂输尿管狭窄[J]. 北京大学学报（医学版）, 2024, 56(4): 640-645. |
| [3] | 兰东,刘茁,李宇轩,王国良,田晓军,马潞林,张树栋,张洪宪. 根治性肾切除和静脉癌栓取出术大出血的危险因素[J]. 北京大学学报（医学版）, 2023, 55(5): 825-832. |
| [4] | 刘茁,朱国栋,唐世英,洪鹏,赵勋,张启鸣,李丽伟,彭冉,陈志刚,王滨帅,张丽,杨飞龙,葛力源,孙争辉,张树栋,王国良,田晓军,张洪宪,马潞林. 外科手术治疗年龄≥75岁的高龄肾细胞癌合并静脉癌栓患者的临床经验[J]. 北京大学学报（医学版）, 2022, 54(4): 774-778. |
| [5] | 左炜,高菲,袁昌巍,熊盛炜,李志华,张雷,杨昆霖,李新飞,刘靓,魏来,张鹏,王冰,谷亚明,朱宏建,赵峥,李学松. 基于多中心数据库的10年上尿路修复手术术式及术型变化趋势[J]. 北京大学学报（医学版）, 2022, 54(4): 692-698. |
| [6] | 秦彩朋,宋宇轩,丁梦婷,王飞,林佳兴,杨文博,杜依青,李清,刘士军,徐涛. 肾癌免疫治疗疗效评估突变预测模型的建立[J]. 北京大学学报（医学版）, 2022, 54(4): 663-668. |
| [7] | 周利群,徐纯如. 机器人时代中央型肾肿瘤的手术治疗策略[J]. 北京大学学报（医学版）, 2022, 54(4): 587-591. |
| [8] | 洪鹏,田晓军,赵小钰,杨飞龙,刘茁,陆敏,赵磊,马潞林. 肾移植术后双侧乳头状肾癌1例[J]. 北京大学学报（医学版）, 2021, 53(4): 811-813. |
| [9] | 郝瀚,刘越,陈宇珂,司龙妹,张萌,范宇,张中元,唐琦,张雷,吴士良,宋毅,林健,赵峥,谌诚,虞巍,韩文科. 机器人辅助前列腺癌根治术后患者的控尿恢复时间[J]. 北京大学学报（医学版）, 2021, 53(4): 697-703. |
| [10] | 肖若陶,刘承,徐楚潇,何为,马潞林. 术前血小板参数与局部进展期肾细胞癌预后[J]. 北京大学学报（医学版）, 2021, 53(4): 647-652. |
| [11] | 程嗣达,李新飞,熊盛炜,樊书菠,王杰,朱伟杰,李子奡,丁光璞,俞婷,李万强,孙永明,杨昆霖,张雷,郝瀚,李学松,周利群. 机器人辅助腹腔镜上尿路修复手术:单一术者108例经验总结[J]. 北京大学学报（医学版）, 2020, 52(4): 771-779. |
| [12] | 徐帅,王旸烁,李纾,刘海鹰. 肾癌及脑膜瘤术后并发吉兰-巴雷综合征1例[J]. 北京大学学报（医学版）, 2019, 51(4): 775-777. |
| [13] | 李丽伟,刘茁,王国良,张华,陈文,马静,张丽,何为,马潞林,王淑敏. 肾癌伴下腔静脉瘤栓合并血栓的多种影像学比较[J]. 北京大学学报（医学版）, 2019, 51(4): 678-683. |
| [14] | 唐琦,林榕城,姚林,张争,郝瀚,张崔建,蔡林,李学松,何志嵩,周利群. 肾癌术后局部复发患者的临床病理特征及预后分析[J]. 北京大学学报（医学版）, 2019, 51(4): 628-631. |
| [15] | 曾鸿，容晓莹，张小青，郭向阳. 肾癌伴下腔静脉癌栓手术中应用回收式自体输血联合白细胞滤器2例[J]. 北京大学学报(医学版), 2017, 49(4): 736-739. |
|
||
